Tumor Embolization Devices Market Soars as Cancer Cases Surge

The Business Research Company’s Tumor Embolization Devices Global Market Report 2023 – Market Size, Trends, And Forecast 2023-2027

LONDON, GREATER LONDON, UK, December 8, 2023 /EINPresswire.com/ -- The tumor embolization devices market has witnessed rapid growth, expanding from $1.62 billion in 2023 to a projected $1.82 billion in 2024, boasting a remarkable Compound Annual Growth Rate (CAGR) of 12.8%. Poised for robust expansion, the market is anticipated to reach $2.83 billion by 2028, maintaining a substantial CAGR of 11.6%.

Market Driver: Global Rise in Cancer Cases

A key driver propelling the growth of the tumor embolization devices market is the surge in global cancer cases. Notably, the American Cancer Society reported approximately 1.9 million new cases and 608,570 cancer-related deaths in the USA in 2021 alone. With lung, prostate, bowel, and female breast cancers comprising 43% of all new cases globally, the escalating incidence of cancer is expected to drive the demand for tumor embolization devices in the coming years.

Explore the Market with a Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3352&type=smp

Emerging Trend: Technological Advancements Enhance Efficacy

In response to the growing demand, companies in the tumor embolization devices market are increasingly investing in technological advancements. One noteworthy trend is the development of biocompatible, biodegradable, drug-eluting microspheres that enhance the efficiency of embolization. These innovative microspheres effectively block blood vessels supplying tumors without causing prolonged blockage of healthy tissue blood vessels. For instance, Emboline secured a $55 million investment in May 2021 to develop and launch embolic protection catheters, demonstrating the industry's commitment to advancing technology.

Market Segmentation
1) By Type: Radioembolic Agents, Non-radioactive Embolic Agents
2) By Application: Cancer Tumors, Noncancerous Tumors
3) By End User: Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers

Regional Dynamics: North America Leads, Asia-Pacific Follows

In 2023, North America emerged as the largest region in the tumor embolization devices market, driven by a robust healthcare infrastructure and a high prevalence of cancer cases. Asia-Pacific secured the second-largest position, reflecting a rising awareness of minimally invasive cancer treatments and increasing healthcare investments in the region.

Access the Complete Report for In-Depth Analysis:
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

Tumor Embolization Devices Global Market Report 2023 from TBRC covers the following information:
• Market size date for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Tumor Embolization Devices Global Market Report 2023 by The Business Research Company is the most comprehensive report that provides insights on tumor embolization devices market size, tumor embolization devices market drivers and trends, tumor embolization devices market major players, tumor embolization devices market competitors' revenues, tumor embolization devices market positioning, and market growth across geographies. The tumor embolization devices market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Tumor Ablation Therapy Devices Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

Solid Tumor Cancer Treatment Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-

Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/tumor-necrosis-factor-inhibitor-drugs-global-market-report

About The Business Research Company?
The Business Research Company has published over 3000+ detailed industry reports, spanning over 6500+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Food and Beverages Market Growth Forecast 2023-2027